An interventional study of alternative medicine education consultation in Breast Cancer, Non-metastatic and Newly Diagnosed, sponsored by University Hospital, Grenoble. Recruiting at 2 sites in France. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-16.
Sponsored by University Hospital, Grenoble · Not applicable, Interventional, and Other
Shared Decision Making on Care Pathways and alternative and complementary medicine (CAMs) : A Pilot Study.
Study whose aim is to evaluate the feasibility of a study proposing a therapeutic education consultation leaning on the usual care pathway by estimating the recruitment capacity over 4 months as well as the acceptance rate of the study among patients diagnosed with breast cancer.
The use of alternative and complementary medicine (CAMs) has been steadily increasing for several years. Certain populations are more likely than others to use this type of care, including breast cancer patients, for whom the rate of use is close to 90%. However, these populations are those for whom the risks associated with this type of care are the highest. In addition, patients rarely discuss alternative and complementary medicine (CAMs) with conventional care teams. As a result, patients often place unreasonable expectations on alternative and complementary medicine (CAMs) and at the same time put themselves in risky situations.
The aim of this project is to help breast cancer patients better orient themselves in their care pathway and in particular with regard to the plethora of alternative and complementary medicine (CAMs) available. They could therefore make an informed decision to seek (or not) treatment. In order to reach a shared decision, a consultation will be offered to patients with the objective of discussing their past recourse, their knowledge of the care pathway, their fears and their aspirations with regard to alternative and complementary medicine (CAM). Epistemological concepts (self-efficacy, placebo, benefit-risk ratio, etc.) will be discussed in order to allow these elements to be transposed throughout their care.
The impact of this consultation on compliance with conventional treatment, satisfaction with the treatment as a whole and communication with the rest of the health care team will be evaluated. A before/after methodology will first allow us to evaluate the values taken by our judgement criteria in the usual care pathway and then in the innovative care pathway proposed by the intervention. This study will allow us to establish the feasibility of a future research project of larger scale.
12,547 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.
This study's planned enrollment of 100 is above the median of 72 across 9,305 interventional studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →University Hospital, Grenoble is the lead sponsor of 816 studies on the registry; 206 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients in the before group are recruited during the first 4 months of the study and will not benefit from the alternative medicine education consultation
Patients in the front group are recruited from the 5th month of the study and will benefit from the alternative medicine education consultation
Other: alternative medicine education consultation
The intervention will consist in a 1h30 individual consultation with a GP physician. Patients will be able to ask any questions they have regarding treatments for their breast cancer delivered outside of the hospital. Topics such as benefit-risk ratios, placebo effects and expectancies from CAM will be discussed with the patients. This consultation will promote a shared-decision model to help patients better discuss these matters with their healthcare providers.
Feasibility of a study proposing a therapeutic education consultation linked to the usual course of care
The investigators wish know the recruitment capacity in this study. To do this, the investigators will estimate the number of people included over 8 months (time of recruitment in the study).
Time frame: 8 month
Evaluate literacy in the care pathway.
"Health Literacy Questionnaire" (HLQ) at 6 month post intervention. Questionnaire contains 2 parts : P1 with 23 questions, and P2 with 21 questions. Coding: P1Q1 to P1Q23 * Strongly Disagree = 1 * Disagree = 2 * Agree = 3 * Strongly Agree = 4 P2Q1 to P2Q21 * Cannot do or always difficult, = 1 * Usually difficult = 2 * Sometimes difficult = 3 * Usually easy = 4 * Always easy = 5 The HLQ consists of 9 scales representing 9 dimensions of health literacy. Each HLQ scale has 4-6 items. The HLQ does not provide one overall summative score. The scoring of the HLQ is 9 scale scores, calculated by averaging the item scores within each scale with equal weighting. The 9 scale scores will reflect a person's strengths and needs in the different dimensions of health literacy. For Scales 1 to 5, the score range is between 1 and 4 For Scales 6 to 9, the score range is between 1 and 5
Time frame: inclusion, 6 month
Satisfaction with improvement in orientation to the care pathway
To assess the HQL (Health Literacy Questionnaire) Minimal Clinically Interesting Difference at 6 months after the intervention. The investigators wish to assess the Minimal Clinically Interesting Difference at 6 months after the intervention by comparing the response about the satisfaction with improvement in orientation to the care pathway (0: No improvement, 1 : Slight improvement, 2 : Good improvement, 3 : Excellent improvement) " to the HLQ dimensions of interest.
Time frame: 6 month
Success in orienting to the care pathway
The investigators wish to assess PALS by comparing the response to the question "Do you feel able to learn about services and supports to ensure that all your health needs are met? ( YES/NO)" to the HLQ dimensions of interest. PALS will be binary, either patients feel able to orient themselves in the care pathway or they do not feel able to do so
Time frame: inclusion, 6 month
Assess satisfaction with the current care pathway
Bilateral 6-item Likert scale at 6 months after surgery (-3: very dissatisfied to +3 very satisfied )
Time frame: 6 month
Collect the patient experience
Semi-directive interview conducted at 6 months after the intervention. This interview will be carried out only for some patients of the study until data saturation.
Time frame: 6 month
To assess patient adherence, patient believes in the mechanics of TACs operation.
CHBQ questionnaire completed at inclusion (pre-intervention) and at 6 months (post-intervention by the patient. This questionnaire is composed of 10 propositions. The total score varies between 10 (total disagreement with all the proposals) and 70 (total agreement with all the proposals). The authors suggest that above the median score of 40, the respondent has a positive attitude towards TACs and conversely a negative attitude towards TACs for a score below 40.
Time frame: inclusion, 6 month
To assess co-variance between oncologist and patient beliefs in TACs operating mechanisms
CHBQ questionnaire completed by the oncologist at the beginning of the study (before the start of the inclusion). This questionnaire is composed of 10 propositions. The total score varies between 10 (total disagreement with all the proposals) and 70 (total agreement with all the proposals). The authors suggest that above the median score of 40, the respondent has a positive attitude towards TACs and conversely a negative attitude towards TACs for a score below 40.
Time frame: Inclusion
To assess the use of TACs
If individuals have used TACs, then they are offered a simplified and adapted version of the CAMP-Q (Complementary and Alternative Medicine Practitioner Use Questionnaire) completed at inclusion and 6 months after the intervention by the patient. This questionnaire includes 49 questions and the objective will be to evaluate if the patient has used one or more alternative medicines (1) or no alternative medicine (0). It don't have a rating
Time frame: inclusion, 6 month
To assess satisfaction with TACs
Bilateral 6-item Likert scale (-3: very dissatisfied to +3 very satisfied) at baseline and 6 months after the procedure ONLY if at least one complementary alternative technique was checked in answer n°1 of the CAMP Q questionnaire. This is to have a before and after evaluation.
Time frame: inclusion, 6 month
To assess satisfaction with oncology care.
Two-sided 6-item Likert scale (-3: very dissatisfied to +3 very satisfied ) at 6 months post intervention. These goals are only evaluated for patients in the AFTER group
Time frame: 6 month
Assess patient satisfaction with the procedure.
Two-way 6-item Likert scale (-3: very dissatisfied to +3 very satisfied ) evaluated after the intervention and at 6 months. This objective is only evaluated for patients in the AFTER group
Time frame: After intervention, 6 month
Assess patient recommendation of the intervention
Two-way Likert scale with 4 items (-2 not at all agree to +2 completely agree ) evaluated after the intervention and at 6 months. This objective is only evaluated for patients in the AFTER group
Time frame: After intervention, 6 month
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Grenoble